Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline

Cristiano Spada, Jaap Stoker, Onofre Alarcon, Federico Barbaro, Davide Bellini, Michael Bretthauer, Margriet C. De Haan, Jean Marc Dumonceau, Monika Ferlitsch, Steve Halligan, Emma Helbren, Mikael Hellstrom, Ernst J. Kuipers, Philippe Lefere, Thomas Mang, Emanuele Neri, Lucio Petruzziello, Andrew Plumb, Daniele Regge, Stuart A. TaylorCesare Hassan, Andrea Laghi

Research output: Contribution to journalArticle

Abstract

This is an official guideline of the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). It addresses the clinical indications for the use of computed tomographic colonography (CTC). A targeted literature search was performed to evaluate the evidence supporting the use of CTC. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. Main recommendations 1 ESGE/ESGAR recommend computed tomographic colonography (CTC) as the radiological examination of choice for the diagnosis of colorectal neoplasia. ESGE/ESGAR do not recommend barium enema in this setting (strong recommendation, high quality evidence). 2 ESGE/ESGAR recommend CTC, preferably the same or next day, if colonoscopy is incomplete. Delay of CTC should be considered following endoscopic resection. In the case of obstructing colorectal cancer, preoperative contrast-enhanced CTC may also allow location or staging of malignant lesions (strong recommendation, moderate quality evidence). 3 When endoscopy is contraindicated or not possible, ESGE/ESGAR recommend CTC as an acceptable and equally sensitive alternative for patients with symptoms suggestive of colorectal cancer (strong recommendation, high quality evidence). 4 ESGE/ESGAR recommend referral for endoscopic polypectomy in patients with at least one polyp  ≥  6  mm in diameter detected at CTC. CTC surveillance may be clinically considered if patients do not undergo polypectomy (strong recommendation, moderate quality evidence). 5 ESGE/ESGAR do not recommend CTC as a primary test for population screening or in individuals with a positive first-degree family history of colorectal cancer (CRC). However, it may be proposed as a CRC screening test on an individual basis providing the screenee is adequately informed about test characteristics, benefits, and risks (weak recommendation, moderate quality evidence).

Original languageEnglish
Pages (from-to)897-915
Number of pages19
JournalEndoscopy
Volume46
Issue number10
DOIs
Publication statusPublished - Oct 1 2014

Fingerprint

Computed Tomographic Colonography
Gastrointestinal Endoscopy
Guidelines
Radiology
Colorectal Neoplasms
Colonoscopy
Polyps
Early Detection of Cancer
Endoscopy
Referral and Consultation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Clinical indications for computed tomographic colonography : European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline. / Spada, Cristiano; Stoker, Jaap; Alarcon, Onofre; Barbaro, Federico; Bellini, Davide; Bretthauer, Michael; De Haan, Margriet C.; Dumonceau, Jean Marc; Ferlitsch, Monika; Halligan, Steve; Helbren, Emma; Hellstrom, Mikael; Kuipers, Ernst J.; Lefere, Philippe; Mang, Thomas; Neri, Emanuele; Petruzziello, Lucio; Plumb, Andrew; Regge, Daniele; Taylor, Stuart A.; Hassan, Cesare; Laghi, Andrea.

In: Endoscopy, Vol. 46, No. 10, 01.10.2014, p. 897-915.

Research output: Contribution to journalArticle

Spada, C, Stoker, J, Alarcon, O, Barbaro, F, Bellini, D, Bretthauer, M, De Haan, MC, Dumonceau, JM, Ferlitsch, M, Halligan, S, Helbren, E, Hellstrom, M, Kuipers, EJ, Lefere, P, Mang, T, Neri, E, Petruzziello, L, Plumb, A, Regge, D, Taylor, SA, Hassan, C & Laghi, A 2014, 'Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline', Endoscopy, vol. 46, no. 10, pp. 897-915. https://doi.org/10.1055/s-0034-1378092
Spada, Cristiano ; Stoker, Jaap ; Alarcon, Onofre ; Barbaro, Federico ; Bellini, Davide ; Bretthauer, Michael ; De Haan, Margriet C. ; Dumonceau, Jean Marc ; Ferlitsch, Monika ; Halligan, Steve ; Helbren, Emma ; Hellstrom, Mikael ; Kuipers, Ernst J. ; Lefere, Philippe ; Mang, Thomas ; Neri, Emanuele ; Petruzziello, Lucio ; Plumb, Andrew ; Regge, Daniele ; Taylor, Stuart A. ; Hassan, Cesare ; Laghi, Andrea. / Clinical indications for computed tomographic colonography : European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline. In: Endoscopy. 2014 ; Vol. 46, No. 10. pp. 897-915.
@article{34e1ff0aadf74f428166e7dcc20f4b16,
title = "Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline",
abstract = "This is an official guideline of the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). It addresses the clinical indications for the use of computed tomographic colonography (CTC). A targeted literature search was performed to evaluate the evidence supporting the use of CTC. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. Main recommendations 1 ESGE/ESGAR recommend computed tomographic colonography (CTC) as the radiological examination of choice for the diagnosis of colorectal neoplasia. ESGE/ESGAR do not recommend barium enema in this setting (strong recommendation, high quality evidence). 2 ESGE/ESGAR recommend CTC, preferably the same or next day, if colonoscopy is incomplete. Delay of CTC should be considered following endoscopic resection. In the case of obstructing colorectal cancer, preoperative contrast-enhanced CTC may also allow location or staging of malignant lesions (strong recommendation, moderate quality evidence). 3 When endoscopy is contraindicated or not possible, ESGE/ESGAR recommend CTC as an acceptable and equally sensitive alternative for patients with symptoms suggestive of colorectal cancer (strong recommendation, high quality evidence). 4 ESGE/ESGAR recommend referral for endoscopic polypectomy in patients with at least one polyp  ≥  6  mm in diameter detected at CTC. CTC surveillance may be clinically considered if patients do not undergo polypectomy (strong recommendation, moderate quality evidence). 5 ESGE/ESGAR do not recommend CTC as a primary test for population screening or in individuals with a positive first-degree family history of colorectal cancer (CRC). However, it may be proposed as a CRC screening test on an individual basis providing the screenee is adequately informed about test characteristics, benefits, and risks (weak recommendation, moderate quality evidence).",
author = "Cristiano Spada and Jaap Stoker and Onofre Alarcon and Federico Barbaro and Davide Bellini and Michael Bretthauer and {De Haan}, {Margriet C.} and Dumonceau, {Jean Marc} and Monika Ferlitsch and Steve Halligan and Emma Helbren and Mikael Hellstrom and Kuipers, {Ernst J.} and Philippe Lefere and Thomas Mang and Emanuele Neri and Lucio Petruzziello and Andrew Plumb and Daniele Regge and Taylor, {Stuart A.} and Cesare Hassan and Andrea Laghi",
year = "2014",
month = "10",
day = "1",
doi = "10.1055/s-0034-1378092",
language = "English",
volume = "46",
pages = "897--915",
journal = "Endoscopy",
issn = "0013-726X",
publisher = "Georg Thieme Verlag",
number = "10",

}

TY - JOUR

T1 - Clinical indications for computed tomographic colonography

T2 - European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline

AU - Spada, Cristiano

AU - Stoker, Jaap

AU - Alarcon, Onofre

AU - Barbaro, Federico

AU - Bellini, Davide

AU - Bretthauer, Michael

AU - De Haan, Margriet C.

AU - Dumonceau, Jean Marc

AU - Ferlitsch, Monika

AU - Halligan, Steve

AU - Helbren, Emma

AU - Hellstrom, Mikael

AU - Kuipers, Ernst J.

AU - Lefere, Philippe

AU - Mang, Thomas

AU - Neri, Emanuele

AU - Petruzziello, Lucio

AU - Plumb, Andrew

AU - Regge, Daniele

AU - Taylor, Stuart A.

AU - Hassan, Cesare

AU - Laghi, Andrea

PY - 2014/10/1

Y1 - 2014/10/1

N2 - This is an official guideline of the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). It addresses the clinical indications for the use of computed tomographic colonography (CTC). A targeted literature search was performed to evaluate the evidence supporting the use of CTC. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. Main recommendations 1 ESGE/ESGAR recommend computed tomographic colonography (CTC) as the radiological examination of choice for the diagnosis of colorectal neoplasia. ESGE/ESGAR do not recommend barium enema in this setting (strong recommendation, high quality evidence). 2 ESGE/ESGAR recommend CTC, preferably the same or next day, if colonoscopy is incomplete. Delay of CTC should be considered following endoscopic resection. In the case of obstructing colorectal cancer, preoperative contrast-enhanced CTC may also allow location or staging of malignant lesions (strong recommendation, moderate quality evidence). 3 When endoscopy is contraindicated or not possible, ESGE/ESGAR recommend CTC as an acceptable and equally sensitive alternative for patients with symptoms suggestive of colorectal cancer (strong recommendation, high quality evidence). 4 ESGE/ESGAR recommend referral for endoscopic polypectomy in patients with at least one polyp  ≥  6  mm in diameter detected at CTC. CTC surveillance may be clinically considered if patients do not undergo polypectomy (strong recommendation, moderate quality evidence). 5 ESGE/ESGAR do not recommend CTC as a primary test for population screening or in individuals with a positive first-degree family history of colorectal cancer (CRC). However, it may be proposed as a CRC screening test on an individual basis providing the screenee is adequately informed about test characteristics, benefits, and risks (weak recommendation, moderate quality evidence).

AB - This is an official guideline of the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). It addresses the clinical indications for the use of computed tomographic colonography (CTC). A targeted literature search was performed to evaluate the evidence supporting the use of CTC. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. Main recommendations 1 ESGE/ESGAR recommend computed tomographic colonography (CTC) as the radiological examination of choice for the diagnosis of colorectal neoplasia. ESGE/ESGAR do not recommend barium enema in this setting (strong recommendation, high quality evidence). 2 ESGE/ESGAR recommend CTC, preferably the same or next day, if colonoscopy is incomplete. Delay of CTC should be considered following endoscopic resection. In the case of obstructing colorectal cancer, preoperative contrast-enhanced CTC may also allow location or staging of malignant lesions (strong recommendation, moderate quality evidence). 3 When endoscopy is contraindicated or not possible, ESGE/ESGAR recommend CTC as an acceptable and equally sensitive alternative for patients with symptoms suggestive of colorectal cancer (strong recommendation, high quality evidence). 4 ESGE/ESGAR recommend referral for endoscopic polypectomy in patients with at least one polyp  ≥  6  mm in diameter detected at CTC. CTC surveillance may be clinically considered if patients do not undergo polypectomy (strong recommendation, moderate quality evidence). 5 ESGE/ESGAR do not recommend CTC as a primary test for population screening or in individuals with a positive first-degree family history of colorectal cancer (CRC). However, it may be proposed as a CRC screening test on an individual basis providing the screenee is adequately informed about test characteristics, benefits, and risks (weak recommendation, moderate quality evidence).

UR - http://www.scopus.com/inward/record.url?scp=84920950124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920950124&partnerID=8YFLogxK

U2 - 10.1055/s-0034-1378092

DO - 10.1055/s-0034-1378092

M3 - Article

C2 - 25268304

AN - SCOPUS:84920950124

VL - 46

SP - 897

EP - 915

JO - Endoscopy

JF - Endoscopy

SN - 0013-726X

IS - 10

ER -